MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma
Tetsu Tomonari(Tokushima University), Tetsuji Takayama(Tokushima University)
Cited by 66
Related Papers
EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer
|Molecular Cancer Research|2017|62
High antitumor activity of pladienolide B and its derivative in gastric cancer
|Cancer Science|2013|52
A Novel Theranostic Combination of Near-infrared Fluorescence Imaging and Laser Irradiation Targeting c-KIT for Gastrointestinal Stromal Tumors
|Theranostics|2018|33
MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
|Cancers|2021|32
JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8
|Gastric Cancer|2019|26